Document:

Exhibit

Exhibit 10.25
REVANCE THERAPEUTICS, INC.
AMENDED AND RESTATED
NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

Each member of the Board of Directors (the “Board”) who is not also serving as an employee of Revance Therapeutics, Inc. (the “Company”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Amended and Restated Non-Employee Director Compensation Policy for his or her Board service.  This policy is effective as of January 1, 2017 (the “Effective Date”) and may be amended at any time in the sole discretion of the Board.

Annual Cash Compensation

The annual cash compensation amount set forth below is payable in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal year, with the pro-rated amount paid for the first fiscal quarter in which the Eligible Director provides the service, and regular full quarterly payments thereafter. All annual cash fees are vested upon payment. 

		
	1.
	Annual Board Service Retainer: 

a.    All Eligible Directors: $39,500
		
	b.
	Chairman of the Board Service Retainer (including Eligible Director Service Retainer): $74,000

2.    Annual Committee Member Service Retainer:
a.    Member of the Audit Committee: $7,500
b.    Member of the Compensation Committee: $5,000
c.    Member of the Nominating & Governance Committee: $4,500
d.    Member of the Science & Technology Committee: $5,000

		
	3.
	Annual Committee Chair Service Retainer (including Committee Member Service Retainer):

a.    Chairman of the Audit Committee: $20,000
b.    Chairman of the Compensation Committee: $12,250
c.    Chairman of the Nominating & Governance Committee: $8,000
d.    Chairman of the Science & Technology Committee: $12,250

Equity Compensation

The equity compensation set forth below will be granted under the Revance Therapeutics, Inc. 2014 Equity Incentive Plan (the “Plan”), and will be documented on the applicable form of stock option agreement most recently approved for use by the Board (or a duly authorized committee thereof) for Eligible Directors. All stock options granted under this policy will be nonstatutory stock options, with an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of the underlying Common Stock on the date of grant, and a term of ten years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Plan).  

1.    Initial Option Grant: On the date of the Eligible Director’s initial election to the Board, for each Eligible Director who is first elected to the Board following the Effective Date (or, if such date is not a 

1.
 
 
 
 
 
125766038 v2 

market trading day, the first market trading day thereafter), the Eligible Director will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option for 18,000 shares (an “Initial Option Grant”).  The shares subject to each Initial Option Grant will vest on the one year anniversary of the date of grant, subject to the Eligible Director’s Continuous Service (as defined in the Plan) through each such vesting date.  

2.    Annual Option Grant: On the date of each Company’s annual stockholder meeting held after the Effective Date, each Eligible Director who continues to serve as a non-employee member of the Board will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option for 6,000 shares (an “Annual Option Grant”). The shares subject to the Annual Option Grant will vest on the one year anniversary of the date of grant, subject to the Eligible Director’s Continuous Service (as defined in the Plan) through such vesting date.

3.    Annual Restricted Stock Award: On the date of each Company’s annual stockholder meeting held after the Effective Date, each Eligible Director who continues to serve as a non-employee member of the Board will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a restricted stock award for 3,000 shares (an “Annual RSA”). The shares underlying the Annual RSA will vest on the one year anniversary of the date of grant, subject to the Eligible Director’s Continuous Service (as defined in the Plan) through such vesting date.
 will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option for 8,000 shares (an “Annual Option Grant”). The shares subject to the Annual Option Grant will vest on the one year anniversary of the date of grant, subject to the Eligible Director’s Continuous Service (as defined in the Plan) through such vesting date.

2.
 
 
 
 
 
125766038 v2Exhibit

Exhibit 10.26
REVANCE THERAPEUTICS, INC. 
2017 MANAGEMENT BONUS PROGRAM 
On January 26, 2017, the Compensation Committee of the Board of Directors of Revance Therapeutics, Inc. (the “Company”) approved the Company’s 2017 corporate objectives, weighted for purposes of determining bonuses, if any, for the Company’s executive officers with respect to performance for fiscal year 2017 (the “2017 Bonus Program”). 
The 2017 Bonus Program is designed to reward, through the payment of annual cash bonuses, the Company’s executive officers for the Company’s performance in meeting key corporate objectives and for individual performance in meeting specified corporate goals for the year. 
The Company’s 2017 corporate goals include the achievement of clinical development milestones for RT002 injectable for the treatment of glabellar (frown) lines, cervical dystonia, and plantar fasciitis (80% weighting), achievement of specified financial objectives (10% weighting), and achievement of objectives related to commercialization readiness (10% weighting), as well as a stretch goal of achieving other research-related milestones (15% weighting).
The cash bonus for L. Daniel Browne will be based on the achievement of the 2017 corporate goals (100% weighting). The cash bonus for Lauren P. Silvernail and Abhay Joshi, Ph.D. will be based on the achievement of the 2017 corporate goals (75% weighting) and his or her individual performance goals (25% weighting). The executive officers’ actual bonuses for fiscal year 2017 may exceed 100% of his or her 2017 target bonus percentage in the event performance exceeds the predetermined goals and/or upon the achievement of other specified goals relating to clinical development. 
Payment of bonuses to the Company’s executive officers under the 2017 Bonus Program and the actual amount of such bonus, if any, are within the discretion of the Compensation Committee. The actual bonus awarded, if any, may be more or less than each executive’s annual target bonus.EX-10.23

 Exhibit 10.23 
  

 
  
 November 7, 2016 

Jeffrey Fowler 
 1927 Nottingham Place 

Fullerton, CA 92835 
 Dear Jeff: 

Welcome to BJ’s Restaurants, Inc. (“Company”). We are delighted to extend you the offer to join the Company as Senior Vice President and
Chief Supply Chain Officer. Your offer is contingent upon the results of a background investigation and your acceptance of these terms. 
 We would like
you to begin on November 21, 2016 (“Effective Date”) at 9:00 AM at the Company Restaurant Support Center located at 7755 Center Avenue, Suite 300, Huntington Beach, CA 92647. Please ask for Jim Farman, Sr. Director of Talent
Development when you arrive. 
 I’d like to recap your offer and outline our plans for you: 

1.            Duties. The Company will employ you as Senior Vice President and Chief Supply
Chain Officer. In this capacity, you will perform such duties as the Company, in the exercise of its sole discretion, deems appropriate for that position. Additionally, in this capacity, you also understand that you may be a “named executive
officer” of the Company as defined by the regulations of the Securities and Exchange Commission and all other applicable laws and regulations. You will report to the Company’s Executive Vice President and Chief Financial Officer (CFO).

 2.            Employment Location. The principal location of your employment will be at
the Company’s Restaurant Support Center in Huntington Beach, California. You also understand that it may be necessary for you to travel to the Company’s restaurant locations and to the offices of the Company’s vendor partners in order
to perform certain aspects of your position. 
 3.            Salary. You will receive a
bi-weekly salary of $10,961.53 which annualizes to a yearly salary of $285,000.00, payable in accordance with the Company’s payroll policies, as such policies may change from time to time (the “Salary”). Your salary package is subject
to modification during your employment in accordance with the Company’s practices, policies and procedures. 

4.            Monthly Auto Allowance. You will also receive a monthly non-accountable
automobile allowance of $1,000.00, less applicable withholdings. The allowance is intended to cover all costs of using your personal automobile for Company business purposes, including gasoline, mileage, insurance and so forth. 

5.            Business Expenses. You will be reimbursed for expenses you incur that are
directly related to the Company’s operations and business, pursuant to the provisions of the Company’s business expense reimbursement policy. A Company-provided business credit card will be issued to you for Company business purposes. You
will receive an unlimited Team Member Courtesy Card for purchase of food and non-alcoholic beverages at any BJ’s Restaurants location. 

6.            Bonus. As a Senior Vice President in our Restaurant Support Center, you will be
eligible to participate in the Company’s Fiscal 2017 Performance Incentive Plan (“2017 PIP”). Your cash incentive opportunity under the PIP will be a maximum of 50% of your Salary for fiscal year 2017, prorated for actual time worked
in 2017 and paid in 2018. Your cash bonus opportunity under the PIP will be driven by the degree of the Company’s achievement of certain financial or operational targets for 2017 as determined annually by the Board of Directors and by the
degree of your timely achievement, as determined by the Chief Executive Officer (“CEO”) in his judgment (and as subsequently approved by the Compensation Committee of the Board of Directors), of certain key initiatives and personal
objectives agreed upon by you and the CEO. Your achievement of any cash bonus is conditional upon achievement of all of the terms of the PIP. These components and your eligibility for any such bonus in 2017 and in subsequent fiscal years are subject
to change, in the sole discretion of the Company’s Board of Directors, provided that you are still employed by the Company in the capacity you are currently being employed or in any other capacity. Your annual cash bonus opportunity is at the
sole discretion of the Company’s Board of Directors and is not earned until it is received. In the event of termination or resignation prior to receipt of any cash incentive, if any, you will not be entitled to, or be considered eligible to,
receive any prorated cash bonus under the Company’s Performance Incentive Plan. Given your start date, you will not be eligible for an incentive under the 2016 PIP. 

7.            Termination With or Without Cause. Your employment is at will and may be
terminated by you or the Company, at any time, with or without notice, and with or without cause. 
  

7755 CENTER AVENUE, SUITE 300    •    HUNTINGTON BEACH, CALIFORNIA
92647    •    (714) 500-2400 MAIN    •    (714) 500-2605 FAX 

WWW.BJSRESTAURANTS.COM 
  

 

 
  

 If the Company terminates your employment without cause, on or after the Effective Date, you will be
eligible to receive a severance payment of six (6) months of your annual base Salary then in effect and, if you are not covered by any other comprehensive group medical insurance plan, the Company will also pay you an amount equivalent to the
employer portion of your COBRA payments for a period of six (6) months. Any severance amounts paid will be based upon your then current annual base Salary at the time employment ends and will be paid in a lump sum, less applicable withholdings.
The aforementioned severance payment is conditioned upon your agreement to release all claims, if any, you may have against the Company and/or any of its employees, officers, directors, agents and representatives, insofar as permissible under the
law. For the purpose of the severance payment provision in this Agreement only, “Cause” shall include, but is not limited to: 

(i)          failure by you to perform your duties expected by the
Company, other than such failure resulting from your incapacity due to physical or mental illness, after there has been delivered to you a written demand for performance from the Company which demand identifies the basis for the Company’s
belief that you have not performed your duties; 

(ii)          dishonesty, incompetence or gross negligence in the
discharge of your duties. 
 (iii)          theft, embezzlement,
fraud, act or acts of dishonesty undertaken by you with the intent of resulting or actually resulting in personal gain or enrichment of you or others at the expense of the Company and/or your conviction of a felony; 

(iv)          breach of confidentiality or unauthorized disclosure or
use of inside information, recipes, processes, customer, vendor or employee lists, trade secrets or other proprietary information; 

(v)          the violation of any law, rule, or regulation of any
governmental authority or breach of the Company’s policies and procedures including, without limitation, the Company’s Code of Integrity, Ethics and Conduct and/or any of its anti-harassment and
anti- discrimination policies; 
 (vi)          a material breach
of the terms and conditions of this Agreement; 

(vii)          conduct that is injurious to the reputation, business
or assets of the Company. 
 You will not be eligible for the severance payments or benefits set forth herein if you resign from your employment with
the Company for any reason or voluntarily terminate your employment 
 8.          Initial Equity
Award. Subject to applicable securities laws, a recommendation will be made to the Compensation Committee of the Company’s Board of Directors to grant you an equity award pursuant to the Company’s 2005 Equity Incentive Plan that will be
valued for financial accounting purposes at $300,000. New hire grants will typically be approved and effective upon the date of the next regularly scheduled Compensation Committee following the Effective Date. If the Board approval date falls within
one of the Company’s insider trading “blackout” periods, then the award grant date will be the first trading day after such “blackout” period is lifted. This award is in the form of an allocation of 50% of the value of the
award to non-qualified stock options (NQs) and the remaining 50% to restricted stock units (RSUs). The number of NQ option shares under the award will be determined using the “fair value” of a NQ
option calculated using the Black-Scholes option pricing model on the grant date of the award. For example, if the “fair value” of a NQ option for the Company’s common stock is $10.00 on the grant date, you would be awarded options to
purchase 15,000 shares of the Company’s common stock ($150,000 / $10.00). The actual “fair value” calculation on the grant date of your award may be higher or lower than this example. The number of RSU shares, if any, will be
determined using the closing price of the Company’s common stock on the Nasdaq Global Market on the grant date of the award. Vesting for this award, regardless of whether it is NQ options or RSUs, will be 20% annually, beginning with the first
anniversary of their grant date, over a total of five (5) years. You may also be eligible for additional grants of equity awards from time to time at the discretion of the Compensation Committee of the Board. 

9.          Other Benefits. You shall be entitled to participate in any benefit plan that the Company
may offer to its employees from time to time, according to the eligibility requirements and terms of such plan, including, but not limited to, the Company’s group medical, dental and vision insurance program, which will become effective the
first of the month following 30 days from your Effective Date. Nothing contained in this Agreement shall affect the right of the Company to terminate or modify any such plan or agreement, or other benefit, in whole or in part, at any time and from
time to time. 
 10.          Paid Absences. The Company does not have a formal paid vacation or
illness policy for its officers. Accordingly, officers are expected to use their reasonable judgment and professional discretion when requesting paid time off for any reason, in light of their current work schedules and the Company’s business
and operational requirements. Paid absences must be reasonably requested in advance and approved by the CFO. 

  
 7755 CENTER AVENUE, SUITE
300    •    HUNTINGTON BEACH, CALIFORNIA 92647    •    (714) 500-2400 MAIN    •    (714) 500-2605 FAX 

WWW.BJSRESTAURANTS.COM 

 

 
  

 11.          Trade Secrets/Confidentiality. You hereby
acknowledge that, as a result of your position with the Company, the Company will give you access to the Company’s proprietary and confidential information and trade secrets. Therefore, as a condition of your employment and the Company’s
disclosing such proprietary and confidential information to you, you agree to sign and be bound by a separate Trade Secrets/Confidentiality Agreement. You also hereby acknowledge that you will not disclose to the Company any confidential,
proprietary and/or trade secret information you obtained while working for any prior employer. 

12.          Arbitration. As a condition of your employment, you agree to sign and be bound by a
separate Arbitration Agreement. Any disputes or controversy arising under or in connection with this Agreement, including but not limited to whether any Cause to dismiss you exists under the provisions of paragraph 7 of this Agreement, shall be
resolved by arbitration conducted in Orange County, California in accordance with the JAMS Employment Arbitration Rules and Procedures and by a single arbitrator reasonably acceptable to both you and the Company. 

13.          Compliance with Company Policies and Procedures. You will be required to comply with the
Company’s policies and procedures, as they may be constituted from time to time. Notwithstanding such policies and procedures, the terms set forth in this Agreement or any other written fully executed agreement between you and the Company shall
prevail over conflicting Company policies and procedures. 
 14.          Severability. If any
provision contained in this Agreement is determined to be void, illegal or unenforceable, in whole or in part, then the other provisions contained herein shall remain in full force and effect as if the provision which was determined to be void,
illegal, or unenforceable had not been contained herein. 
 15.          Other Provisions. By signing
this letter, you acknowledge that the terms described in this letter set forth the entire understanding between the parties concerning the terms of your employment and supersede all prior representations, understandings and agreements, either oral
or in writing, between you and the Company with respect to the terms of your employment by the Company and all such prior representations, understandings and agreements, both oral and written, are hereby terminated. However, nothing in this
paragraph is intended to, nor does it, affect additional written agreements entered into by the parties contemporaneous with or subsequent to this agreement, including, without limitation, the Trade Secrets/Confidentiality Agreement referenced
herein. Nothing in this letter constitutes a guarantee of employment for any period of time, nor does it limit your right, or the right of the Company to end your employment with the Company at any time, for any reason. No term or provision of this
letter may be amended, waived, released, discharged or modified except in writing, signed by you and an authorized officer of the Company. 
 Jeff, we
are excited to have you join our senior leadership team. Please acknowledge your acceptance of this offer of employment on the terms indicated by signing the enclosed copy of this letter and returning it to me as soon as possible. 

Sincerely, 
 /s/ Greg Levin 

Greg Levin 
 Executive Vice President and Chief Financial Officer 

I accept the above offer of employment with BJ’s Restaurants, Inc. on the terms and conditions described in this Agreement. 

 

			
	 /s/ Jeff Fowler
	    	 November 8, 2016

		
	Jeff Fowler	    	Date

  
 7755 CENTER AVENUE, SUITE
300    •    HUNTINGTON BEACH, CALIFORNIA 92647    •    (714) 500-2400 MAIN    •    (714) 500-2605 FAX 

WWW.BJSRESTAURANTS.COM

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]